questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the withdrawal of hydrocortisone sodium phosphate liquid solution from the medicine market on to patients with adrenal insufficiency.
answerText: The Department is aware of the discontinuation of hydrocortisone sodium phosphate 100mg/1ml solution for injection and we continue to work with industry to find a longer-term solution.Hydrocortisone sodium succinate 100mg powder remains available for pati...
heading: Hydrocortisone